Literature DB >> 15026124

Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system.

S T Chen1, J I Chuang, J P Wang, M S Tsai, H Li, N-S Chang.   

Abstract

WW domain-containing oxidoreductase WOX1, also known as WWOX or FOR, is a proapoptotic protein and a putative tumor suppressor. Hyaluronidases such as PH-20, Hyal-1 and Hyal-2 induce the expression of WOX1, and hyaluronidases and hyaluronan are involved in the embryonic development. In the present study, we document the expression of WOX1 in the developing murine nervous system. Immunohistochemical analysis revealed that WOX1 was differentially expressed in early dividing cells from all three germ layers from embryonic to perinatal stages. In murine fetuses, WOX1 was present prevalently in the brainstem, spinal cord and peripheral nerve bundles, but its expression decreased after birth. In parallel, the expression of WOX1, as determined by Western blotting, was significantly reduced in the brain stem and spinal cord of adult mice. Notably, high levels of WOX1 immunoreactivity was observed in the neural crest-derived structures such as cranial and spinal ganglia and cranial mesenchyme during the late fetal stage. In the adult brain, WOX1 is abundant in the epithelial cells of the choroids plexus and ependymal cells, while a low to moderate level of WOX1 is observed within white matter tracts, such as axonal profiles of the corpus callosum, striatum, optic tract, and cerebral peduncle. WOX1 is shown to mediate apoptosis synergistically with p53 in vitro. Nonetheless, the expression profiles of WOX1 were found to be similar in both p53 wild type and knockout mice, suggesting that WOX1 expression is not controlled by p53-mediated gene transcription. Taken together, in this study we have shown the expression and distribution of WOX1 in developing and adult murine nervous system. The potential role of WOX1 in the neuronal differentiation is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026124     DOI: 10.1016/j.neuroscience.2003.12.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  29 in total

1.  A novel missense variant in the SDR domain of the WWOX gene leads to complete loss of WWOX protein with early-onset epileptic encephalopathy and severe developmental delay.

Authors:  Jessika Johannsen; Fanny Kortüm; Georg Rosenberger; Kristin Bokelmann; Markus A Schirmer; Jonas Denecke; René Santer
Journal:  Neurogenetics       Date:  2018-05-28       Impact factor: 2.660

Review 2.  Role of WW domain proteins WWOX in development, prognosis, and treatment response of glioma.

Authors:  Shin-Yi Liu; Ming-Fu Chiang; Yu-Jen Chen
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-27

3.  Introduction to a thematic issue for WWOX.

Authors:  Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03

Review 4.  The fragile site WWOX gene and the developing brain.

Authors:  Brahim Tabarki; Fuad Al Mutairi; Amal Al Hashem
Journal:  Exp Biol Med (Maywood)       Date:  2014-11-21

5.  The tumour suppressor gene WWOX is mutated in autosomal recessive cerebellar ataxia with epilepsy and mental retardation.

Authors:  Martial Mallaret; Matthis Synofzik; Jaeho Lee; Cari A Sagum; Muhammad Mahajnah; Rajech Sharkia; Nathalie Drouot; Mathilde Renaud; Fabrice A C Klein; Mathieu Anheim; Christine Tranchant; Cyril Mignot; Jean-Louis Mandel; Mark Bedford; Peter Bauer; Mustafa A Salih; Rebecca Schüle; Ludger Schöls; C Marcelo Aldaz; Michel Koenig
Journal:  Brain       Date:  2013-12-24       Impact factor: 13.501

Review 6.  Emerging roles for hyaluronidase in cancer metastasis and therapy.

Authors:  Caitlin O McAtee; Joseph J Barycki; Melanie A Simpson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

7.  Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1.

Authors:  Li-Jin Hsu; Lori Schultz; Qunying Hong; Kris Van Moer; John Heath; Meng-Yen Li; Feng-Jie Lai; Sing-Ru Lin; Ming-Hui Lee; Cheng-Peng Lo; Yee-Shin Lin; Shur-Tzu Chen; Nan-Shan Chang
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

8.  Wwox deletion leads to reduced GABA-ergic inhibitory interneuron numbers and activation of microglia and astrocytes in mouse hippocampus.

Authors:  Tabish Hussain; Hyunsuk Kil; Bharathi Hattiangady; Jaeho Lee; Maheedhar Kodali; Bing Shuai; Sahithi Attaluri; Yoko Takata; Jianjun Shen; Martin C Abba; Ashok K Shetty; C Marcelo Aldaz
Journal:  Neurobiol Dis       Date:  2018-10-02       Impact factor: 5.996

Review 9.  Pleiotropic Functions of Tumor Suppressor WWOX in Normal and Cancer Cells.

Authors:  Muhannad Abu-Remaileh; Emma Joy-Dodson; Ora Schueler-Furman; Rami I Aqeilan
Journal:  J Biol Chem       Date:  2015-10-23       Impact factor: 5.157

10.  Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats.

Authors:  Meng-Yen Li; Feng-Jie Lai; Li-Jin Hsu; Chen-Peng Lo; Ching-Li Cheng; Sing-Ru Lin; Ming-Hui Lee; Jean-Yun Chang; Dudekula Subhan; Ming-Shu Tsai; Chun-I Sze; Subbiah Pugazhenthi; Nan-Shan Chang; Shur-Tzu Chen
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.